Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01927302 · ClinicalTrials.gov registry record · NA

Neurobiology of Language Recovery in Aphasia: Natural History and Treatment-Induced Recovery

A NA study, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
90
Enrollment target

NCT01927302 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 90 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01927302, a NA study, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target

Study Summary

The purpose of this study is to investigate the effects of treatment for specific language deficits in people with aphasia. In addition to language and cognitive measures, changes in brain function will also be gathered before and after the treatment is administered in order to track any changes resulting from receiving treatment.

Interventions

  • BEHAVIORAL Treatment Focusing on Naming Objects
  • BEHAVIORAL Treatment Focusing on Improving Spelling Abilities
  • BEHAVIORAL Treatment Focusing on Improving Sentence Processing
  • BEHAVIORAL No Treatment

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2013-04
Est. Completion 2019-03-27
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT01927302

The ClinicalTrials.gov registry entry for NCT01927302 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Treatment Focusing on Naming Objects is the first listed.

NCT01927302 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01927302 about?

NCT01927302 is a clinical study titled "Neurobiology of Language Recovery in Aphasia: Natural History and Treatment-Induced Recovery". The purpose of this study is to investigate the effects of treatment for specific language deficits in people with aphasia. In addition to language and cognitive measures, changes in brain function will also be gathered before and after the treatment is administered in order to track any changes res...

What is the current status of trial NCT01927302?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2013-04. Estimated completion is 2019-03-27.

What interventions are being tested in trial NCT01927302?

The interventions under investigation include: Treatment Focusing on Naming Objects (BEHAVIORAL), Treatment Focusing on Improving Spelling Abilities (BEHAVIORAL), Treatment Focusing on Improving Sentence Processing (BEHAVIORAL), No Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT01927302?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.